Literature DB >> 15284478

Molecular analysis of SV-40-CAL, a new slow growing SV-40 strain from the kidney of a caged New World monkey with fatal renal disease.

Jacqueline M Zdziarski1, Nicolene A Sarich, Kelley E Witecki, John A Lednicky.   

Abstract

A decline of the Callimico goeldii population in American zoos is presently occurring due to glomerulonephritis of unknown etiology. We hypothesized that this emerging idiopathic fatal renal disease (IFRD) was caused by a virus. We therefore attempted to isolate virus from the kidneys three C. goeldi in Illinois that had IFRD. Along with other viruses, Simian virus 40 (SV-40) strain CAL was isolated. SV-40-CAL is currently the slowest-growing natural isolate of SV-40 in CV-1 cells. Inefficient SV-40-CAL growth in CV-1 cells stems from two features: a suboptimal protoarchetypal regulatory region, and a Large tumor antigen gene sequence like that of SV-40 strain T302, previously considered the slow-growing natural isolate of SV-40. To our knowledge, this is the first documented isolation of SV-40 from a New World monkey outside of a laboratory setting. Though SV-40 is renaltropic, the role of SV-40-CAL in IFRD is uncertain. Transmission of SV-40 to C. goeldii through anthropogenic activity is suspected.

Entities:  

Mesh:

Year:  2004        PMID: 15284478     DOI: 10.1023/B:VIRU.0000036378.42136.7c

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  16 in total

1.  Induced latent infection of monkeys with vacuolating SV-40 Papova virus. Virus in kidneys and urine.

Authors:  A ASHKENAZI; J L MELNICK
Journal:  Proc Soc Exp Biol Med       Date:  1962-11

2.  Artificial modification of the viral regulatory region improves tissue culture growth of SV40 strain 776.

Authors:  J A Lednicky; C Wong; J S Butel
Journal:  Virus Res       Date:  1995-02       Impact factor: 3.303

3.  A coupled PCR and restriction digest method for the detection and analysis of the SV40 regulatory region in infected-cell lysates and clinical samples.

Authors:  J A Lednicky; J S Butel
Journal:  J Virol Methods       Date:  1997-02       Impact factor: 2.014

4.  Association of simian virus 40 with a central nervous system lesion distinct from progressive multifocal leukoencephalopathy in macaques with AIDS.

Authors:  M A Simon; P O Ilyinskii; G B Baskin; H Y Knight; D R Pauley; A A Lackner
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

5.  Identification of SV40 in brain, kidney and urine of healthy and SIV-infected rhesus monkeys.

Authors:  J S Newman; G B Baskin; R J Frisque
Journal:  J Neurovirol       Date:  1998-08       Impact factor: 2.643

Review 6.  Polyomaviruses and human tumors: a brief review of current concepts and interpretations.

Authors:  J A Lednicky; J S Butel
Journal:  Front Biosci       Date:  1999-02-15

7.  Simian virus 40-associated fatal interstitial pneumonia and renal tubular necrosis in a rhesus monkey.

Authors:  W D Sheffield; J D Strandberg; L Braun; K Shah; S S Kalter
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

8.  Two synthetic Sp1-binding sites functionally substitute for the 21-base-pair repeat region to activate simian virus 40 growth in CV-1 cells.

Authors:  J Lednicky; W R Folk
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

Review 9.  Cell and molecular biology of simian virus 40: implications for human infections and disease.

Authors:  J S Butel; J A Lednicky
Journal:  J Natl Cancer Inst       Date:  1999-01-20       Impact factor: 13.506

10.  Molecular identification of SV40 infection in human subjects and possible association with kidney disease.

Authors:  Rui-Mei Li; Mary H Branton; Somsak Tanawattanacharoen; Ronald A Falk; J Charles Jennette; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

View more
  1 in total

Review 1.  Polyomaviruses of nonhuman primates: implications for research.

Authors:  Meredith A Simon
Journal:  Comp Med       Date:  2008-02       Impact factor: 0.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.